DSM and Evonik Settle on Nebraska as a Site for Omega 3 Production

9d8c8f65-0fa6-490f-84c1-8ecb30972fc3articleimage.jpg

16 Jun 2017 --- Evonik and Royal DSM have settled on Blair, Nebraska, as the location for the commercial-scale production facility for their omega 3 fatty acids from natural marine algae for animal nutrition. DSM Nutritional Products and Evonik Nutrition & Care plan to invest around US$200 million in the facility (US$100 million by each party over approximately two years). 

The initial annual production capacity will meet roughly 15 percent of the current total annual demand for EPA and DHA by the salmon aquaculture industry. The facility is expected to come on stream in 2019. The establishment of the joint venture, to be named Veramaris and headquartered in The Netherlands, will be finalized subject to regulatory approvals. 

Both companies announced in March 2017 the start of a joint venture for this purpose, which will allow for the production of omega 3 fatty acids for animal nutrition without using any fish oil from wild caught fish, a finite resource. Initial applications will be in salmon aquaculture and pet food. 

“With currently 17% of the world’s wild caught fish being used to produce fish oil for aquaculture, we believe this is unsustainable,” Herman Betten, Global Director External Affairs, Royal DSM, explained to NutritionInsight. “By producing omega 3 with EPA and DHA from algae, we will enable the aquaculture industry to grow sustainably.”

DSM’s and Evonik’s highly concentrated algal oil will enable the animal nutrition industry to keep up with the increasing demand for these two essential omega 3 fatty acids without endangering fish stocks, helping to contribute to healthy animal nutrition as well as to the ecological balance and biodiversity of the oceans. 

Nebraska was chosen as it takes advantage of Evonik’s decades of operational experience for large-scale biotechnology operations. The company has been operating a facility there for the fermentative production of Biolys the amino acid L-lysine for almost 20 years. As an investor and employer, Evonik has built a consistent reputation in the local community. The new plant will be located adjacent to Evonik’s current facility on Cargill’s site, with access to the raw materials needed to produce the high value and pure EPA+DHA omega 3 fatty acid oil. 

Until the facility in Blair opens, DSM and Evonik announced they will produce pilot-scale quantities of the algal oil at DSM’s production facility in Kingstree, South Carolina (US). Customers will be able to receive sizeable quantities of the product for market development while the construction of the new manufacturing plant gets underway.

Related Articles

Nutrition & Health News

Food for the heart (Part 2): Consumer trends and innovations

19 Oct 2017 --- Food for heart health is a key trend in nutrition NPD, with many companies exploring ways in which to protect consumers against cardiovascular issues. Today, in the second part of a special report, NutritionInsight examines which consumer trends are driving innovation in the world of heart health products and what these innovations are.

Nutrition & Health News

Food for the heart (Part 1): Opportunities, challenges and delivery forms

16 Oct 2017 --- Heart health is literally a matter of life and death – according to the US Centers for Disease Control and Prevention (CDC), about 610,000 people die of heart disease in the US every year. This means that it accounts for 1 in every 4 deaths. Indeed, heart disease is the leading cause of death for both men and women, so potential nutritional solutions are at the forefront of companies’ thinking.

Nutrition & Health News

Eye health: Lutein and zeaxanthin could help EU save billions in healthcare costs

13 Oct 2017 --- Savings of €6.20 billion (US$7.33 billion) a year could be generated through the daily consumption of 10mg of lutein in combination with 2mg of zeaxanthin by adults aged 50 and older in the EU with age-related macular degeneration (AMD). This is according to a new study produced by Frost & Sullivan.

Nutrition & Health News

Omega 6 rich diet linked to significantly reduced Type 2 diabetes risk

12 Oct 2017 --- The risk of developing Type 2 diabetes could be significantly reduced by eating a diet rich in omega 6 polyunsaturated fats, a new study suggests. These findings, published in The Lancet Diabetes & Endocrinology, shed new light on the potential health benefits of omega 6, which is found in bean and seed oils such as soybean and sunflower oils and in nuts. They also support clinical recommendations to increase dietary intake of omega 6 rich foods.

Nutrition & Health News

“Ridiculously healthy” elderly have same gut microbiome as healthy 30-year-olds, according to study

12 Oct 2017 --- A potential strong link between healthy aging and a healthy gut has been shown by one of the largest microbiota studies conducted in humans. The China-Canada Institute researchers studied the gut bacteria in a cohort of more than 1,000 Chinese people in a variety of age ranges from 3 to over 100 years old. The subjects were self-selected to be extremely healthy with no known health issues and no family history of disease. The results showed a direct correlation between health and the microbes in the intestine.

More Articles
URL : http://www.nutritioninsight.com:80/news/dsm-and-evonik-settle-on-nebraska-as-a-site-for-omega-3-production.html